SC
EW icon

Syon Capital’s Edwards Lifesciences EW Stock Holding History

Syon Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Buy
8,091
+791
+11% +$65.2K 0.03% 462
2025
Q4 		$622K Buy
7,300
+541
+8% +$44.4K 0.03% 479
2025
Q3 		$526K Buy
6,759
+861
+15% +$67.3K 0.03% 478
2025
Q2 		$461K Buy
5,898
+1,227
+26% +$91.5K 0.03% 401
2025
Q1 		$339K Sell
4,671
-136
-3% -$9.73K 0.03% 389
2024
Q4 		$356K Buy
+4,807
New +$336K 0.03% 362
2024
Q3 		– Sell
-3,748
Closed -$346K – 473
2024
Q2 		$346K Sell
3,748
-131
-3% -$11.6K 0.03% 323
2024
Q1 		$371K Buy
+3,879
New +$326K 0.04% 317

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Syon Capital's EW Position: Q1 2026 in Review

Syon Capital increased its Edwards Lifesciences (EW) stake by 11% in Q1 2026, buying an estimated $65.2K and bringing the position to 8,091 shares worth $648K. The position accounts for 0.03% of the portfolio, ranked #462.

Syon Capital first reported a position in EW in Q1 2024 and has held it in 8 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Syon Capital held 8,091 shares of Edwards Lifesciences worth $648K as of Q1 2026.
  • Syon Capital bought 791 Edwards Lifesciences shares in Q1 2026, an estimated $65.2K.
  • Edwards Lifesciences made up 0.03% of Syon Capital's portfolio in Q1 2026, its #462 holding.
  • Syon Capital first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 8 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.